The prevalence and spectrum of thyroid dysfunction among children with Down syndrome attending the paediatric services at two tertiary hospitals in Pretoria, South Africa
Article Sidebar
Main Article Content
Abstract
Background. Down syndrome (DS) is the most common chromosomal abnormality in the paediatric setting, and thyroid dysfunction is more commonly encountered in this population than among the general population. The literature shows that the most common type of thyroid dysfunction seen in these children is subclinical hypothyroidism.
Objective. The purpose of this study was to establish the prevalence and spectrum of thyroid disease in this population with the aim of establishing easy-to-follow protocols.
Method. A retrospective study was conducted in children with DS who were seen at the paediatric genetic clinic at two academic hospitals. Data were collected from the hospital files and the results were extracted from the National Health Laboratory Service database system.
Results. A total of 158 children were recruited; 25 children were excluded as they had had no thyroid function tests done. From the total of 133 included children, 70 (52.6%) were male. Babies born in one of the two hospitals numbered 60 (45.1%), whereas 54.9% were born in the other hospital. A total of 77 (57.9%) were found to have thyroid dysfunction; 55.8% of these patients were male. The most common thyroid abnormality was subclinical hypothyroidism in n=66/133 (49.6%), accounting for 85.7% of the causes of the thyroid dysfunction. Most children (n=45/133 (33.8%)) had their first thyroid function test done before the age of 2 months, followed by the age group of 1 - 5 years (n=34/133 (25.56%)). The total number of children started on treatment for their thyroid dysfunction was n=5/77 (6.49%).
Conclusion. Thyroid dysfunction is seen more commonly in children with DS compared with the general population, which was very evident in the present study. A standardised protocol will have a significant impact on the early management of these children, to prevent further cognitive impairment, especially in developing countries and at any level of healthcare. The recommendations for thyroid dysfunction screening by the American Academy of Pediatrics can be adjusted and tailored for the South African population. Early diagnosis and referral of children with DS to a secondary- or tertiary-level facility is of utmost benefit for these children for screening and treatment of comorbidities and complications.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The SAJCH is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
Bull MJ. Down syndrome. N Eng J Med 2020;382(24):2344-2352.
Chandra N, Cyril C, Lakshminarayana P, et al. Cytogenetic evaluation of Down syndrome: A review of 1020 referral cases. Int J Human Genet 2010;10(1-3):87-93.
Devlin L, Morrison P. Accuracy of the clinical diagnosis of Down syndrome. Ulster Med J 2004;73(1):4-12.
Bull MJ, Trotter T, Santoro SL, Christensen C, Grout RW. Health supervision for children and adolescents with Down syndrome. Pediatrics 2022;149(5):1-24.
Iughetti L, Lucaccioni L, Fugetto F, Mason A, Predieri B. Thyroid function in Down syndrome. Expert Rev Endocrinol Metab 2015;10(5):525-532.
Murphy J, Philip M, Macken S, et al. Thyroid dysfunction in Down’s syndrome and screening for hypothyroidism in children and adolescents using capillary TSH measurement. J Pediatric Endocrinol Metabol 2008;21(2):155-164.
Gibson P, Newton R, Selby K, Price D, Leyland K, Addison G. Longitudinal study of thyroid function in Down’s syndrome in the first two decades. Arch Dis Childhood 2005;90(6):574-578.
Oliveira A, Longui CA, Calliari E, Ferone EdA, Kawaguti FS, Monte O. Evaluation of the hypothalamic-pituitary-thyroid axis in children with Down syndrome. J Pediatr (Rio J) 2002;78(4):295-300.
Purdy I, Singh N, Brown W, Vangala S, Devaskar U. Revisiting early hypothyroidism screening in infants with Down syndrome. J Perinatol 2014;34(12):936-940.
Bull MJ. Health supervision for children with Down syndrome. Pediatrics 2011;128(2):393-406.
Moosa S, Segal DG, Christianson AL, Gregersen NE. Thyroid dysfunction in a cohort of South African children with Down syndrome. S Afr Med J 2013;103(12):966-970.
Chapman RS, Hesketh LJ. Behavioral phenotype of individuals with Down syndrome. Ment Retard Dev Disabil Res Rev. 2000;6(2):84-95.
Petersen M, Mikkelsen M. Nondisjunction in trisomy 21: Origin and mechanisms. Cytogen Genome Res 2000;91(1-4):199-203.
Kruger E, Coetzee A, Conradie M, Hoffmann M. An audit of thyroid function testing in acutely ill patients at a South African academic hospital. Southern Afr J Crit Care 2020;36(1):46-50.
Vadakedom SS, Krishnan DK, Mammen DS, KP B, Antony JM. Medical problems in children with Down syndrome. Int J Adv Med 2018;5(5):1290-1294.
MacGillivray MH, Aceto T, Frohman LA. Plasma growth hormone responses and growth retardation of hypothyroidism. Am J Dis Children 1968;115(2):273-276.
Karlsson B, Gustafsson J, Hedov G, Ivarsson S, Annerén G. Thyroid dysfunction in Down’s syndrome: Relation to age and thyroid autoimmunity. Arch Dis Childhood 1998;79(3):242-245.
Pierce MJ, LaFranchi SH, Pinter JD. Characterisation of thyroid abnormalities in a large cohort of children with Down syndrome. Horm Res Paediatr 2017;87(3):170-178.
Fergeson MA, Mulvihill JJ, Schaefer GB, et al. Low adherence to national guidelines for thyroid screening in Down syndrome. Genetics Med 2009;11(7):548-551.
Mulu B, Fantahun B. Thyroid abnormalities in children with Down syndrome at St. Paul’s Hospital Millennium Medical College, Ethiopia. Endocrinol Diabetes Metabol 2022;00:e337.
Del Ghianda S, Tonacchera M, Vitti P. Thyroid and menopause. Climacteric 2014;17(3):225-234.
Kanike N, Davis A, Shekhawat PS. Transient hypothyroidism in the newborn: To treat or not to treat. Translational Pediatrics 2017;6(4):349.
Metwalley KA, Farghaly HS. Endocrinal dysfunction in children with Down syndrome. Ann Pediatric Endocrinol Metabol 2022;27(1):15.
Amr NH. Thyroid disorders in subjects with Down syndrome: An update. Acta Bio Medica: Atenei Parmensis 2018;89(1):132.
Crisafulli G, Aversa T, Zirilli G, et al. Subclinical hypothyroidism in children: When a replacement hormonal treatment might be advisable. Front Endocrin 2019;10:109.
Bittles AH, Bower C, Hussain R, Glasson EJ. The four ages of Down syndrome. Eur J Public Health 2007;17(2):221-225.
Marder L, Tulloh R, Pascall E. Cardiac problems in Down syndrome. Paediatrics and Child Health 2015;25(1):23-29.
Charleton PM, Dennis J, Marder E. Medical management of children with Down syndrome. Paediatrics and Child Health 2010;20(7):331-337.